Pfizer accused of mismarketing Neurontin; Type 1 diabetes vaccine may help with management;

> Once again, Pfizer faces allegations that it has been marketing its drug Neurontin deceptively, putting a positive spin on what was actually negative research. FiercePharma

> This may offer some new help with one of the world's most common and expensive chronic illnesses. A new vaccine developed by a Swedish team of scientists may help children and adolescents diagnosed with Type 1 diabetes better manage the disease, researchers say. FierceVaccines

> Blue Cross is having a knock-down, drag-out dispute with the Care New England Hospital group, and no one's sure how things will shake out in the market if they don't work it out quickly. Article

> Is running a hospital anything like being a band leader? Retired hospital CEO Nick Jacobs explains why he believes it is. HospitalImpact

And Finally... Even for free, I doubt this would be worth the hassle. But hey, there is the Benji factor. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.